NCX 285
Alternative Names: AZD 4717Latest Information Update: 31 Jul 2012
At a glance
- Originator NicOx
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis
Most Recent Events
- 27 Jul 2012 Discontinued - Preclinical for Osteoarthritis in Europe (unspecified route)
- 15 Mar 2005 Preclinical trials in Osteoarthritis in Europe (unspecified route)
- 14 Mar 2004 Preclinical trials in Inflammation in Europe (unspecified route)